130 related articles for article (PubMed ID: 11369055)
1. Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma.
Vettenranta K; Aalto Y; Wikström S; Knuutila S; Saarinen-Pihkala U
Cancer Genet Cytogenet; 2001 Mar; 125(2):125-30. PubMed ID: 11369055
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.
Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA
Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670
[TBL] [Abstract][Full Text] [Related]
3. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
Vandesompele J; Speleman F; Van Roy N; Laureys G; Brinskchmidt C; Christiansen H; Lampert F; Lastowska M; Bown N; Pearson A; Nicholson JC; Ross F; Combaret V; Delattre O; Feuerstein BG; Plantaz D
Med Pediatr Oncol; 2001 Jan; 36(1):5-10. PubMed ID: 11464905
[TBL] [Abstract][Full Text] [Related]
4. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
[TBL] [Abstract][Full Text] [Related]
5. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
Plantaz D; Vandesompele J; Van Roy N; Lastowska M; Bown N; Combaret V; Favrot MC; Delattre O; Michon J; Bénard J; Hartmann O; Nicholson JC; Ross FM; Brinkschmidt C; Laureys G; Caron H; Matthay KK; Feuerstein BG; Speleman F
Int J Cancer; 2001 Mar; 91(5):680-6. PubMed ID: 11267980
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Boecker W; Lampert F; Stoerkel S
J Pathol; 1997 Apr; 181(4):394-400. PubMed ID: 9196436
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization (CGH): ten years of substantial progress in human solid tumor molecular cytogenetics.
Gebhart E
Cytogenet Genome Res; 2004; 104(1-4):352-8. PubMed ID: 15162064
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
10. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization.
Vandesompele J; Van Roy N; Van Gele M; Laureys G; Ambros P; Heimann P; Devalck C; Schuuring E; Brock P; Otten J; Gyselinck J; De Paepe A; Speleman F
Genes Chromosomes Cancer; 1998 Oct; 23(2):141-52. PubMed ID: 9739017
[TBL] [Abstract][Full Text] [Related]
11. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
Tomioka N; Oba S; Ohira M; Misra A; Fridlyand J; Ishii S; Nakamura Y; Isogai E; Hirata T; Yoshida Y; Todo S; Kaneko Y; Albertson DG; Pinkel D; Feuerstein BG; Nakagawara A
Oncogene; 2008 Jan; 27(4):441-9. PubMed ID: 17637744
[TBL] [Abstract][Full Text] [Related]
12. [Synopsis of unbalanced chromosome aberrations in neuroblastoma by comparative genomic hybridization].
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Böcker W; Störkel S
Pathologe; 1996 Sep; 17(5):368-73. PubMed ID: 8992479
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.
Villamón E; Piqueras M; Mackintosh C; Alonso J; de Alava E; Navarro S; Noguera R
Virchows Arch; 2008 Jul; 453(1):47-55. PubMed ID: 18574593
[TBL] [Abstract][Full Text] [Related]
14. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG
Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325
[TBL] [Abstract][Full Text] [Related]
15. Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Depuydt P; Boeva V; Hocking TD; Cannoodt R; Ambros IM; Ambros PF; Asgharzadeh S; Attiyeh EF; Combaret V; Defferrari R; Fischer M; Hero B; Hogarty MD; Irwin MS; Koster J; Kreissman S; Ladenstein R; Lapouble E; Laureys G; London WB; Mazzocco K; Nakagawara A; Noguera R; Ohira M; Park JR; Pötschger U; Theissen J; Tonini GP; Valteau-Couanet D; Varesio L; Versteeg R; Speleman F; Maris JM; Schleiermacher G; De Preter K
J Natl Cancer Inst; 2018 Oct; 110(10):1084-1093. PubMed ID: 29514301
[TBL] [Abstract][Full Text] [Related]
16. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
Khan FH; Pandian V; Ramraj S; Natarajan M; Aravindan S; Herman TS; Aravindan N
BMC Cancer; 2015 Jul; 15():514. PubMed ID: 26159519
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
18. [Tumor cytogenetics and prognosis in neuroblastoma].
Christiansen H; Lampert F
Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
[TBL] [Abstract][Full Text] [Related]
19. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
20. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization.
Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
Genes Chromosomes Cancer; 1996 Feb; 15(2):89-94. PubMed ID: 8834171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
